Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11325972
APP PUB NO 20200071395A1
SERIAL NO

16575903

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, the present invention relates generally to the treatment of eosinophilic bronchitis with an anti-IL-5 antibody or fragment thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GLAXOSMITHKLINE, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hargreave, Fredrick E Hamilton, CA 3 29
Ventresca, Giampietro Hertfordshire, GB 3 29

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 10, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 10, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 10, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00